Patients with brain and urologic cancers will soon have access to a broader array of the latest treatment options here, thanks to new clinical trials at Carilion Clinic for targeted radiopharmaceutical therapies.
Radiopharmaceuticals, also known as “theranostics,” is a form of precision medicine that uses radioactive isotopes for both imaging and therapy, and has been shown to be effective in treating a wide range of tumors.
In the pipeline are new theranostic treatment trials for cancer pain, renal cell carcinoma and glioblastoma. They build on the health system’s earlier research in partnership with Blue Ridge Cancer Care that has attracted patients from across the country and led to FDA approval of therapies in use today, including Pluvicto (Lu177PSMA) and Lutathera (dotatate)…